Q and A: about health and research

Introduction Every cell in the human body requires a constant supply of energy to survive and function. Under normal conditions, cells generate most of this energy through oxidative phosphorylation, a highly efficient process occurring inside mitochondria that requires oxygen. However, when oxygen becomes scarce—a condition known as hypoxia —cells must rapidly adapt to survive. This adaptation is orchestrated primarily by Hypoxia-Inducible Factor-1 (HIF-1) , a master regulator that shifts cellular metabolism away from oxygen-dependent energy production toward glycolysis, an alternative pathway capable of generating energy without oxygen. While this response is essential during normal physiological conditions such as intense exercise or high-altitude exposure, it can also contribute to disease progression, particularly in cancer. Glycolysis: The Cell's Emergency Energy System Glycolysis is the metabolic pathway that breaks glucose into pyruvate, producing small amounts of ATP, the c...

The emergence of SARS-CoV-2 (COVID-19) has unveiled a complex interplay between the virus and the host's hematopoietic system, leading to significant haematological manifestations. Among these, disruptions in erythropoiesis , dysregulation of hepcidin , and the effects of the cytokine storm on red blood cell production and iron metabolism have been widely observed. This article delves into these critical aspects to shed light on the pathophysiological mechanisms behind COVID-19-related haematological abnormalities. Erythropoiesis in the Context of SARS-CoV-2 Erythropoiesis, the process by which red blood cells (RBCs) are produced, is a highly regulated system that ensures the continuous supply of oxygen to tissues. Disruptions in erythropoiesis have been noted in COVID-19 patients, often manifesting as anemia or altered red blood cell indices. Impact of SARS-CoV-2 on Erythropoiesis Hypoxia and Erythropoietin (EPO) Dysregulation : COVID-19 frequently induces hypoxemia due to respi...

An elevated number of erythrocytes (red blood cells or RBCs) and hemoglobin in the blood can indicate a condition known as polycythemia , or more specifically, polyglobulia . While this can be a temporary and benign finding, it may also be a sign of a more serious underlying health issue — particularly a bone marrow disorder such as Polycythemia Vera (PV) . In this article, we explore what elevated RBC and hemoglobin levels mean, what can cause them, and how PV fits into the picture. What Is an Elevated RBC Count? Red blood cells (erythrocytes) play a crucial role in transporting oxygen from the lungs to the body’s tissues. Hemoglobin , the iron-containing protein in RBCs, is responsible for binding to and carrying oxygen. Normal RBC Count In a healthy person, the RBC count typically falls within a specific range, usually measured in millions of cells per microliter (million/µL) of blood. These ranges vary slightly based on age, sex, and laboratory standards. An RBC count is co...